Sugi Predict

Sugi Predict / Targets / TUBGCP2

TUBGCP2

Gamma-tubulin complex component 2 · Q9BSJ2 · TUBGCP2 on Sugi Atlas →

0 patent compounds predicted against TUBGCP2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TUBGCP2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU) PHASE2/PHASE3ACTIVE_NOT_RECRUITING
Impact of tdrd9 Gene Mutations in the Therapeutic Response to L-carnitine in Oligoasthenozoospermic Men PHASE3ACTIVE_NOT_RECRUITING
A Multicenter Study of NAP (AL-108) in Schizophrenia PHASE2COMPLETED
Study of ABT-751 in Patients With Refractory Hematologic Malignancies PHASE1COMPLETED
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype EARLY_PHASE1COMPLETED
Genetic Study of Patients With Primary Ciliary Dyskinesia nanCOMPLETED
PCD New Gene Discovery nanCOMPLETED
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Genetics of Primary Ciliary Dyskinesia nanCOMPLETED
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Evaluation of Possible Genes in Periodontal Diseases by Genetic Methods nanUNKNOWN
Mapping Disease Pathways for Biliary Atresia nanRECRUITING
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Early Detection and Characterization of Primary Ciliary Dyskinesia nanUNKNOWN
Thermal Spa Treatment and Improvement of Primary Ciliary Dyskinesia nanRECRUITING
Familial Intracranial Aneurysm Study II nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Phenotype/Genotype Correlations in Neuromuscular Disorders nanCOMPLETED
Genetics and Psychopathology in the 22q11 Deletion Syndrome nanUNKNOWN
Biomarker Research in Inherited Movement Disorders nanRECRUITING
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
Genetic Basis of Non Syndromic Congenital Diaphragmatic Hernia nanCOMPLETED
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Mapping Novel Disease Genes for Dilated Cardiomyopathy nanCOMPLETED
Transcranial Magnetic Stimulation (TMS) Studies of Dystonia nanCOMPLETED
The Genetic Characterization of Dementia nanCOMPLETED
Myotubular Myopathy Genetic Testing Study nanCOMPLETED
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a TUBGCP2 binder may also engage these)

ProteinNameSimilarity
Q5R5J6 — 1.000 Q5R5J6 →
Q921G8 — 1.000 Q921G8 →
Q961G1 — 0.986 Q961G1 →
Q29N70 — 0.986 Q29N70 →
Q9FG37 — 0.985 Q9FG37 →
Q8CI04 — 0.985 Q8CI04 →
Q9JJA2 — 0.984 Q9JJA2 →
Q9XYP7 — 0.984 Q9XYP7 →
G5EGS5 — 0.983 G5EGS5 →
Q6NMI3 — 0.983 Q6NMI3 →
Q9VVG4 — 0.983 Q9VVG4 →
Q16ZN9 — 0.983 Q16ZN9 →
F4HQ84 — 0.982 F4HQ84 →
Q8MSY4 — 0.982 Q8MSY4 →
Q8RW96 — 0.982 Q8RW96 →
Q9Y705 — 0.981 Q9Y705 →
Q86T65 — 0.981 Q86T65 →
Q9VLC0 — 0.980 Q9VLC0 →
P34561 — 0.980 P34561 →
Q9Y6D5 — 0.980 Q9Y6D5 →
Q2KI89 — 0.980 Q2KI89 →
COG3 Conserved oligomeric Golgi complex subunit 3 0.979 landscape →
Q9VKH0 — 0.979 Q9VKH0 →
Q24087 — 0.979 Q24087 →
Q7TQK5 — 0.979 Q7TQK5 →
F4JHH5 — 0.979 F4JHH5 →
Q7ZX96 — 0.979 Q7ZX96 →
Q6GQI5 — 0.979 Q6GQI5 →
Q3SYW6 — 0.979 Q3SYW6 →
COG2 Conserved oligomeric Golgi complex subunit 2 0.979 landscape →